Operating income decreased 171.1%
Operating income changed -171.1% from the comparable as-filed period.
-$2.1M→-$5.6M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →UAVS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Research & development increased 144.5%
Research & development changed +144.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$810,990→$2.0M3 prior comparisons
Shares outstanding increased 84.8%
Shares outstanding changed +84.8% from the comparable as-filed period. The change ranks at the 29th percentile of 7 prior comparable changes.
34,032,333→62,905,7067 prior comparisons
Gross profit decreased 41.9%
Gross profit changed -41.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$2.3M→$1.4M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.